Pharmaceutical innovation holds immense societal and economic value. Medicines contribute significantly to improving the quality of life in our society. It is therefore crucial to ensure that the development of innovative medicines, from the initial phase to actual production, proceeds as efficiently and effectively as possible. PharmaNL aims to strengthen the pharmaceutical value chain within the Netherlands and address bottlenecks, specifically by Creating a shared infrastructure for the development, scaling, and production of innovative medicines in the Netherlands, for use by pharmaceutical start-ups, scale-ups, and academic research groups, and enhancing the pharmaceutical education offerings (human capital) with international appeal and attractiveness.

Discover more about the possibilities of PharmaNL (by Brigitte Drees), the projects in Shared Infrastructure and Human Capital Growth that were granted (by Peter Ketelaar and Pedro Hermkens) and learn more about the upcoming subsidy round that will open up in March 2025, for Shared Infrastructure. The session will be hosted by Jon de Vlieger, from Lygature.